Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bridget Quinn, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Le HM, Stracciolini A, Stein CJ, Quinn BJ, Jackson SS. Platelet rich plasma for hallux sesamoid injuries: a case series. Phys Sportsmed. 2021 Aug 18; 1-4. PMID: 34346850.
    Citations:    Fields:    
  2. Sugimoto D, Gearhart MG, Kobelski GP, Quinn BJ, Geminiani ET, Stracciolini A. Hallux Sesamoid Injury Characteristics in Young Athletes Presented to the Sports Medicine Clinic. Clin J Sport Med. 2021 Mar 01. PMID: 33852435.
    Citations:    Fields:    
  3. Quinn BJ, Scott C, Stracciolini A. Special Considerations for Growing Dancers. Phys Med Rehabil Clin N Am. 2021 02; 32(1):75-86. PMID: 33198900.
    Citations:    Fields:    Translation:Humans
  4. Sugimoto D, Zwicker RL, Quinn BJ, Myer GD, Stracciolini A. Part II: Comparison of Crossfit-Related Injury Presenting to Sports Medicine Clinic by Sex and Age. Clin J Sport Med. 2020 05; 30(3):251-256. PMID: 31842052.
    Citations: 2     Fields:    Translation:Humans
  5. Stracciolini A, Quinn B, Zwicker RL, Howell DR, Sugimoto D. Part I: Crossfit-Related Injury Characteristics Presenting to Sports Medicine Clinic. Clin J Sport Med. 2020 03; 30(2):102-107. PMID: 32073473.
    Citations: 2     Fields:    Translation:Humans
  6. Yin AX, Geminiani E, Quinn B, Owen M, Kinney S, McCrystal T, Stracciolini A. The Evaluation of Strength, Flexibility, and Functional Performance in the Adolescent Ballet Dancer During Intensive Dance Training. PM R. 2019 07; 11(7):722-730. PMID: 30758918.
    Citations:    Fields:    Translation:Humans
  7. Stracciolini A, Quinn BJ, Geminiani E, Kinney S, McCrystal T, Owen M, Pepin MJ, Stein CJ. Body Mass Index and Menstrual Patterns in Dancers. Clin Pediatr (Phila). 2017 Jan; 56(1):49-54. PMID: 27090151.
    Citations: 2     Fields:    
  8. Howell DR, Mannix RC, Quinn B, Taylor JA, Tan CO, Meehan WP. Physical Activity Level and Symptom Duration Are Not Associated After Concussion. Am J Sports Med. 2016 Apr; 44(4):1040-6. PMID: 26838933.
    Citations: 12     Fields:    Translation:Humans
  9. Wilson JC, Quinn BJ, Stratton CW, Southwick H, MacDonald JP. Athletes Doing Arabesques: Important Considerations in the Care of Young Dancers. Curr Sports Med Rep. 2015 Nov-Dec; 14(6):448-54. PMID: 26561765.
    Citations: 1     Fields:    Translation:Humans
  10. Carsen S, Quinn BJ, Beck E, Southwick H, Micheli LJ. "Nutcracker Fracture" in a Ballet Dancer Performing in The Nutcracker. J Dance Med Sci. 2015 Sep; 19(3):124-7. PMID: 26349506.
    Citations: 1     Fields:    Translation:Humans
  11. Wu B, Wang S, De SK, Barile E, Quinn BA, Zharkikh I, Purves A, Stebbins JL, Oshima RG, Fisher PB, Pellecchia M. Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells. Chem Biol. 2015 Jul 23; 22(7):876-887. PMID: 26165155.
    Citations: 12     Fields:    Translation:HumansAnimalsCells
  12. Maji S, Samal SK, Pattanaik L, Panda S, Quinn BA, Das SK, Sarkar D, Pellecchia M, Fisher PB, Dash R. Mcl-1 is an important therapeutic target for oral squamous cell carcinomas. Oncotarget. 2015 Jun 30; 6(18):16623-37. PMID: 26009874.
    Citations: 16     Fields:    Translation:HumansAnimalsCells
  13. Quinn BA, Dash R, Sarkar S, Azab B, Bhoopathi P, Das SK, Emdad L, Wei J, Pellecchia M, Sarkar D, Fisher PB. Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline. Cancer Res. 2015 Jun 01; 75(11):2305-15. PMID: 26032425.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  14. Quinn BA, Lee NA, Kegelman TP, Bhoopathi P, Emdad L, Das SK, Pellecchia M, Sarkar D, Fisher PB. The Quest for an Effective Treatment for an Intractable Cancer: Established and Novel Therapies for Pancreatic Adenocarcinoma. Adv Cancer Res. 2015; 127:283-306. PMID: 26093904.
    Citations: 4     Fields:    Translation:HumansAnimals
  15. Sarkar S, Quinn BA, Shen XN, Dash R, Das SK, Emdad L, Klibanov AL, Wang XY, Pellecchia M, Sarkar D, Fisher PB. Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic. Oncotarget. 2015 May 10; 6(13):10712-27. PMID: 25926554.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  16. Sarkar S, Quinn BA, Shen X, Dent P, Das SK, Emdad L, Sarkar D, Fisher PB. Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene therapy approach. Mol Pharmacol. 2015 Feb; 87(2):286-95. PMID: 25452327.
    Citations: 4     Fields:    Translation:HumansCells
  17. Bhoopathi P, Quinn BA, Gui Q, Shen XN, Grossman SR, Das SK, Sarkar D, Fisher PB, Emdad L. Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid. Cancer Res. 2014 Nov 01; 74(21):6224-35. PMID: 25205107.
    Citations: 12     Fields:    Translation:HumansCells
  18. Azab BM, Dash R, Das SK, Bhutia SK, Sarkar S, Shen XN, Quinn BA, Dent P, Dmitriev IP, Wang XY, Curiel DT, Pellecchia M, Reed JC, Sarkar D, Fisher PB. Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV). J Cell Physiol. 2014 Jan; 229(1):34-43. PMID: 23868767.
    Citations: 15     Fields:    Translation:HumansAnimalsCells
  19. Thomas S, Quinn BA, Das SK, Dash R, Emdad L, Dasgupta S, Wang XY, Dent P, Reed JC, Pellecchia M, Sarkar D, Fisher PB. Targeting the Bcl-2 family for cancer therapy. Expert Opin Ther Targets. 2013 Jan; 17(1):61-75. PMID: 23173842.
    Citations: 77     Fields:    Translation:HumansAnimals
  20. Hedvat M, Emdad L, Das SK, Kim K, Dasgupta S, Thomas S, Hu B, Zhu S, Dash R, Quinn BA, Oyesanya RA, Kegelman TP, Sokhi UK, Sarkar S, Erdogan E, Menezes ME, Bhoopathi P, Wang XY, Pomper MG, Wei J, Wu B, Stebbins JL, Diaz PW, Reed JC, Pellecchia M, Sarkar D, Fisher PB. Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules. Anticancer Agents Med Chem. 2012 Nov; 12(9):1143-55. PMID: 22931411.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  21. Azab B, Dash R, Das SK, Bhutia SK, Shen XN, Quinn BA, Sarkar S, Wang XY, Hedvat M, Dmitriev IP, Curiel DT, Grant S, Dent P, Reed JC, Pellecchia M, Sarkar D, Fisher PB. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells. J Cell Physiol. 2012 May; 227(5):2145-53. PMID: 21780116.
    Citations: 25     Fields:    Translation:HumansAnimalsCells
  22. Das SK, Bhutia SK, Kegelman TP, Peachy L, Oyesanya RA, Dasgupta S, Sokhi UK, Azab B, Dash R, Quinn BA, Kim K, Barral PM, Su ZZ, Boukerche H, Sarkar D, Fisher PB. MDA-9/syntenin: a positive gatekeeper of melanoma metastasis. Front Biosci (Landmark Ed). 2012 Jan 01; 17:1-15. PMID: 22201728.
    Citations: 34     Fields:    Translation:HumansCells
  23. Quinn BA, Dash R, Azab B, Sarkar S, Das SK, Kumar S, Oyesanya RA, Dasgupta S, Dent P, Grant S, Rahmani M, Curiel DT, Dmitriev I, Hedvat M, Wei J, Wu B, Stebbins JL, Reed JC, Pellecchia M, Sarkar D, Fisher PB. Targeting Mcl-1 for the therapy of cancer. Expert Opin Investig Drugs. 2011 Oct; 20(10):1397-411. PMID: 21851287.
    Citations: 78     Fields:    Translation:HumansAnimals
  24. Dash R, Azab B, Quinn BA, Shen X, Wang XY, Das SK, Rahmani M, Wei J, Hedvat M, Dent P, Dmitriev IP, Curiel DT, Grant S, Wu B, Stebbins JL, Pellecchia M, Reed JC, Sarkar D, Fisher PB. Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity. Proc Natl Acad Sci U S A. 2011 May 24; 108(21):8785-90. PMID: 21555592.
    Citations: 62     Fields:    Translation:HumansAnimalsCells
  25. Quinn BA, Xiao F, Bickel L, Martin L, Hua X, Klein-Szanto A, Connolly DC. Development of a syngeneic mouse model of epithelial ovarian cancer. J Ovarian Res. 2010 Oct 19; 3:24. PMID: 20958993.
    Citations: 24     Fields:    
  26. Dash R, Bhutia SK, Azab B, Su ZZ, Quinn BA, Kegelmen TP, Das SK, Kim K, Lee SG, Park MA, Yacoub A, Rahmani M, Emdad L, Dmitriev IP, Wang XY, Sarkar D, Grant S, Dent P, Curiel DT, Fisher PB. mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity. Cytokine Growth Factor Rev. 2010 Oct; 21(5):381-91. PMID: 20926331.
    Citations: 52     Fields:    Translation:HumansAnimalsCells
  27. Quinn BA, Brake T, Hua X, Baxter-Jones K, Litwin S, Ellenson LH, Connolly DC. Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53. PLoS One. 2009 Dec 31; 4(12):e8404. PMID: 20046879.
    Citations: 28     Fields:    Translation:HumansAnimalsCells
  28. Hensley H, Quinn BA, Wolf RL, Litwin SL, Mabuchi S, Williams SJ, Williams C, Hamilton TC, Connolly DC. Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer. . 2007 Nov; 6(11):1717-25. PMID: 17986851.
    Citations: 30     Translation:Animals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Quinn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (158)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.